|
71 |
A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study
Enthalten in BMC pharmacology & toxicology Bd. 14, 5.1.2013, Nr. 1, date:12.2013: 1-19
|
|
|
|
72 |
Bioequivalence Evaluation in Healthy Volunteers: New Generic Formulations of Sitagliptin and Sitagliptin–Metformin Fixed-Dose Combination Compared with the Originator Products
Enthalten in Diabetes therapy Bd. 14, 16.12.2022, Nr. 2, date:2.2023: 347-362
|
|
|
|
73 |
Bioequivalence Studies of New Generic Formulations of Vildagliptin and Fixed-Drug Combination of Vildagliptin and Metformin Versus Respective Originator Products in Healthy Volunteers
Enthalten in Diabetes therapy Bd. 13, 11.5.2022, Nr. 6, date:6.2022: 1215-1229
|
|
|
|
74 |
Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 Versus Originator Insulin Aspart Mix 70/30 (NovoMix 30) in People with Diabetes: A 26-Week, Randomized, Open-Label Trial (GEMELLI M)
Enthalten in Diabetes therapy Bd. 13, 14.4.2022, Nr. 5, date:5.2022: 1053-1071
|
|
|
|
75 |
ChemInform Abstract: A Case for August Wilhelm Hofmann as the Originator of the Field of Organophosphorus Chemistry
Enthalten in ChemInform Bd. 44, 2013, Nr. 38: no-no. 1 S.
|
|
|
|
76 |
Cleft lip: The historical perspective
Enthalten in Indian journal of plastic surgery Bd. 42, 2009, Nr. S 01, 01: S4-S8
|
|
|
|
77 |
Comparability of Biosimilar Filgrastim with Originator Filgrastim: Protein Characterization, Pharmacodynamics, and Pharmacokinetics
Enthalten in BioDrugs Bd. 29, 3.4.2015, Nr. 2, date:4.2015: 123-131
|
|
|
|
78 |
Comparative Efficacy and Safety of Biosimilar Rituximab and Originator Rituximab in Rheumatoid Arthritis and Non-Hodgkin’s Lymphoma: A Systematic Review and Meta-analysis
Enthalten in BioDrugs Bd. 33, 24.8.2019, Nr. 5, date:10.2019: 469-483
|
|
|
|
79 |
Comparative Safety of Originator and Biosimilar Epoetin Alfa Drugs: An Observational Prospective Multicenter Study
Enthalten in BioDrugs Bd. 32, 20.7.2018, Nr. 4, date:8.2018: 367-375
|
|
|
|
80 |
Comparison of originator and biosimilar monoclonal antibodies using HRMS, Fc affinity chromatography, and 2D-HPLC
Enthalten in Analytical and bioanalytical chemistry Bd. 414, 27.7.2022, Nr. 23, date:9.2022: 6761-6769
|
|
Administration
